English | Español
Patient Daily Report | Jul 18, 2023

USGS' Smalling: 'The study estimates that at least one type of PFAS ... could be present in nearly half of the tap water in the U.S.'
Patient Daily Report | Jun 27, 2023

Dr. Peter Marks: 'Today's approval addresses an urgent unmet medical need'
Patient Daily Report | May 25, 2023

FDA approves Opvee, prescription nasal spray opioid reversal agent
Patient Daily Report | May 24, 2023

Survey reveals high levels of financial stress among American workforce; 64% of workers living paycheck to paycheck
Patient Daily Report | May 23, 2023

Doctor says innovative technology will 'provide the Type 1 diabetes community with additional options and flexibilities for diabetes management'
Patient Daily | May 18, 2023

Zynex Announces Proposed $50 Million Offering of Convertible Senior Notes
Patient Daily | May 18, 2023

Zynex Announces Proposed Secondary Public Offering of Common Stock
Patient Daily | May 18, 2023

Zynex Announces Update Regarding Previously Announced Offerings

Trending
+ Pharmaceuticals
Patient Daily | Jun 18, 2025

ENT specialist on acid reflux: ‘You actually have a structural issue that may predispose you to sinusitis’
+ Pharmaceuticals
Patient Daily | Jun 16, 2025

American Consumer Institute questions hospital use of 340B Drug Pricing Program
+ Pharmaceuticals
Patient Daily | Jun 13, 2025

Data scientist: ‘340B sales growth was 115.5% higher than the growth of non-340B sales in 2023’
+ Pharmaceuticals
Patient Daily | Jun 19, 2025

Patients Come First spokesperson on 340B reform: ‘Americans deserve a system that prioritizes patients first, not pharmacy middlemen’